NVCR FY 2018 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

FY 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$248M+40.1% YoY

Gross Profit

$168M67.7% margin

Operating Income

-$34M-13.6% margin

Net Income

-$64M-25.6% margin

EPS (Diluted)

$-0.69

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$9M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$340M

Total Liabilities

$228M

Stockholders' Equity

$112M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$248M	$177M	+40.1%
Gross Profit	$168M	$121M	+38.4%
Operating Income	-$34M	-$39M	+14.4%
Net Income	-$64M	-$62M	-3.1%